| Followers | 71 |
| Posts | 10390 |
| Boards Moderated | 0 |
| Alias Born | 01/04/2007 |
Sunday, October 18, 2020 3:41:53 PM
You can also look at it as they are the only ones allowed to sell it, but that doesn't mean they don't have to purchase it to then sell it.
So it's a bit confusing.
So it's a bit confusing.
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
